Swallow whole. Avoid bedtime dosing. ≥18yrs: initially 100mg twice daily for at least 3 days; if tolerated, increase to 100mg 3 times daily at least 6hrs apart; max increase 100mg/day per 3-day period ...

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Bupropion Hydrochloride (CAS 31677-93-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added ...

PITTSBURGH, Aug. 22, 2013 -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company has received approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug ...

January 5, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for ondasetron tablets, orally disintegrating tablets, and oral solution for the prophylaxis of ...

The European Commission has granted marketing authorization for naltrexone HCl/bupropion HCl prolonged release (Mysimba, Orexigen Therapeutics) for the treatment of obesity, the company has announced.

The tablets are available in 100 mg, 150 mg and 200 mg Dr Reddy’s Laboratories has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg. It is a therapeutic ...

Although bupropion hydrochloride extended-release tablets (SR) is not indicated for treatment of depression, it contains the same active ingredient as the antidepressant medications WELLBUTRIN®, ...

LA JOLLA, Calif., Dec. 19, 2014 /PRNewswire/ -- Orexigen Therapeutics (NASDAQ: OREX) announced today that the Committee for Medicinal Products For Human Use (CHMP) of the European Medicines Agency ...

IntelGenx Corp announced that the US Patent and Trademark Office (US PTO) issued patent number 7,674,479 on March 9, 2010 for a key patent application protecting IntelGenx's CPI-300, a novel, high ...

The mechanism of action of bupropion is unknown, as is the case with other antidepressants. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.